Immuneering Corp — Director's Dealing 2022

Aug 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2022-08-11

Reporting Person: Morales Mallory (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-11	Stock Option	$6.33	A	10000	Acquired	2032-08-11	Class A Common Stock (10000)	Direct

Footnotes

F1: 100% of the option vests and becomes exercisable on August 11, 2023, subject Ms. Morales' continued employment through such date.